ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasia: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues.

Mednet Member

Medical Oncology · University of Iowa Carver College of Medicine

Unfortunately there is no safety data for the use of PRRT in patients with GFR <30 ml/min. A creatinine clearance <50 ml/min is listed only as a relative contraindication by NANETS/SNMI (Hope et al 2020) and ENETS guidelines (Hicks et al 2017). Based on over 2 decades of experience with PRRT, the lo...